Comparative analysis of direct renin levels and plasma renin activity for the purpose of monitoring the patients with congenital adrenal cortical hyperplasia

Cover Page


The high prevalence of diseases associated with the disturbances in the renin-angiotensin-aldosterone system (RAAS) including those affecting the children dictates the necessity of the development and application of highly specific, accurate, and sensitive indices. One of them widely used at present is plasma renin activity (PRA). Meanwhile, foreign researchers have demonstrated significant correlation between PRA and direct renin concentration that can be determined by a technically simpler and readily available method. We are unaware of the studies with the application of this approach reported in the Russian-language publications. The present work was designed to consider the possibility of using direct rennin levels and PRA for monitoring health conditions of the children presenting with congenital adrenal cortical hyperplasia. PRA and direct rennin concentrations were determined with the use of the relevant assay kits in 72 patients admitted to the Pediatric Department of Endocrinological Research Centre. Group 1 was comprised of 44 patients presenting with congenital adrenal cortical hyperplasia (CAH), group 2 consisted of 28 patients with the presumably unaffected adrenal function. Direct rennin concentrations and PRA are known to have virtually identical diagnostic value, i.e. they can equally well be used to diagnose disorders of RAAS functions including those in the patients with CAH. However, the measurement of direct rennin permits to more precisely detect hyperaldosteronism and identify children exhibiting symptoms of mineralocorticoid overdose. The patients with the supposedly normal functioning adrenal glands were also found to show high percentage of abnormal PRA values and direct rennin levels which suggests the relationship between the functions of RAAS and other endocrine organs.

About the authors

T A Ionova


G S Kolesnikova

N Iu Kalinchenko


  1. Asbert M., Jiménez W., Gaya J., Ginés P., Arroyo V., Rivera F., Rodés J.J. Comparison between plasma renin activity and direct measurement of immunoreactive renin. Assessment of the renin-angiotensin system in cirrhotic patients. Hepatol 1992; 15: 1-2: 179-183.
  2. Tsunoda K., Abe K., Yasujima M., Seino M., Imai Y., Sato M., Omata K., Kudou K., Takeuchi K., Hagino T. et al. Comparison of immunoreactive renin and plasma renin activity in human plasma. J Exp Med 1989; 158: 3: 179-186.
  3. White P.C., Speiser P.W. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000; 21: 3: 245-291.
  4. Plouin P.F., Cudek P., Arnal J.F., Guyene T.T., Corvol P. Immunoradiometric assay of active renin versus determination of plasma renin activity in the clinical investigation of hypertension, congestive heart failure, and liver cirrhosis. Horm Res 1990; 34: 3-4: 138-141.
  5. Griffiths K.D., Anderson J.M., Rudd B.T., Virdi N.K., Holder G., Rayner P.H. Plasma renin activity in the management of congenital adrenal hyperplasia. Arch Dis Child 1984; 59: 4: 360-365.
  6. Trenkel S., Seifarth C., Schobel H. et al. Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism. Exp Clin Endocrinol Diabet 2002; 110: 80-85.
  7. Fiselier T., Derkx F., Monnens L., Van Munster P., Peer P., Schalekamp M. The basal levels of active and inactive plasma renin concentration in infancy and childhood. Clin Sci (Lond) 1984; 67: 4: 383-387.
  8. Krüger C., Höper K., Weissörtel R., Hensen J., Dörr H.G. Value of direct measurement of active renin concentrations in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Eur J Pediatr 1996; 155: 10: 858-861.
  9. Гончаров Н.П., Кация Г.В., Колесникова Г.С. и др. Гормональный анализ в диагностике болезней эндокринных желез М: АдамантЪ 2009.
  10. Fiselier T.J., Lijnen P., Monnens L., van Munster P., Jansen M., Peer P. Levels of renin, angiotensin I and II, angiotensin-converting enzyme and aldosterone in infancy and childhood. Eur J Pediat 1983; 141: 1: 3-7.
  11. Ресурсы интернета:
  12. Sealey J.E. Plasma renin activity and plasma prorenin assays. Clin Chem 1991; 37: 10: Pt 2: 1811-1819.
  13. Nicar M.J. Specimen processing and renin activity in plasma. Clin Chem 1992; 38: 4: 598.
  14. Zuo W.M., Pratt R.E., Heusser C.H., Bews J.P., de Gasparo M.M., Dzau V.J. Characterization of a monoclonal antibody specific for human active renin. Hypertension 1992; 19: 3: 249-254.
  15. Blazy I., Guillot F., Laborde K., Dechaux M. Сomparison of plasma renin and prorenin in healthy infants and children as determined with an enzymatic method and a new direct immunoradiometric assay. Scand J Clin Lab Invest 1989; 49: 5: 413-418.
  16. Dessì-Fulgheri P., Cocco F., Glorioso N., Bandiera F., Madeddu P., Rappelli A. Immunoradiometric assay of active renin in human plasma: comparison with plasma renin activity. Clin Exp Hypertens A 1987; 9: 8-9: 1383-1390.
  17. Simon D., Hartmann D.J., Badouaille G., Caillot G., Guyenne T.T., Corvol P., Pau B. Two-site direct immunoassay specific for active renin. Marchand J Clin Chem 1992; 38: 10: 1959-1962.
  18. Corbin F., Douville P., Lebel M. Active renin mass concentration to determine aldosterone-to-renin ratio in screening for primary aldosteronism. Int J Nephrol Renovasc Dis 2011; 4: 115-120.
  19. Wu V.C., Kuo C.C., Chang H.W. et al. Diagnosis of primary aldosteronism: comparison of post-captopril active renin concentration and plasma renin activity. Clin Chim Acta 2010; 411: 657-663.
  20. Perschel F.H., Schemer R., Seiler L. et al. Rapid screening test for primary hyperaldosteronism: ratio of plasma aldosterone to renin concentration determined by fully automated chemiluminescence immunoassays. Clin Chem 2004; 50: 1650-1655.
  21. Rossi G.P., Barisa M., Belfiore A. et al. The aldosterone-renin ratio based on the plasma renin activity and direct renin assay for diagnosing aldosterone-producing adenoma. J Hypertens 2010; 28: 1892-1899.
  22. Nimkarn S., Lin-Su K., Berglind N., Wilson R.C., New M.I. Aldosterone-to-renin ratio as a marker for disease severity in 21-hydroxylase deficiency congenital adrenal hyperplasia. J Clin Endocrinol Metabol 2007; 92: 1: 137-142.



Abstract - 920

PDF (Russian) - 7223




Copyright (c) 2013 Ionova T.A., Kolesnikova G.S., Kalinchenko N.I.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies